Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Arthritis Research & Therapy|July 23, 2025
Prevalence and outcomes of a pilot definition of severe refractory systemic lupus erythematosus: observations from a multinational Asia-Pacific cohortRangi Kandane-Rathnayake, Worawit Louthrenoo, C S Lau, et al.
Rheumatology (Oxford, England)|December 10, 2024
Association of lupus low disease activity state and remission with reduced organ damage and flare in systemic lupus erythematosus patients with high disease activity: a multi-national, longitudinal cohort studyRangi Kandane-Rathnayake, Vera Golder, Worawit Louthrenoo, et al.
The Lancet. Rheumatology|January 22, 2024
Impact of low disease activity, remission, and complete remission on flares following tapering of corticosteroids and immunosuppressive therapy in patients with systemic lupus erythematous: a multinational cohort studyJiacai Cho, Liang Shen, Molla Huq, et al.
The Journal of Rheumatology|March 15, 2024
Comparison of Attainment and Protective Effects of Lupus Low Disease Activity State in Patients With Newly Diagnosed Versus Established Systemic Lupus ErythematosusVera Golder, Rangi Kandane-Rathnayake, Worawit Louthrenoo, et al.
Arthritis Care & Research|September 16, 2025
Prevalence, Determinants, and Outcomes of Low Disease Activity and Remission Attainment in Patients With Systemic Lupus Erythematosus That Is Clinically ActiveYanjie Hao, Dylan Hansen, Rangi Kandane-Rathnayake, et al.
Lupus Science & Medicine|February 12, 2025
Time trends of variability in disease activity in systemic lupus erythematosusNing Li, Alberta Hoi, Shue-Fen Luo, et al.
Rheumatology (Oxford, England)|May 11, 2026
Predictive correlates of arthritis and joint damage in systemic lupus erythematosus: a multinational prospective cohort studyLuigi Zolio, Yanjie Hao, Rangi Kandane-Rathnayake, et al.
The Lancet. Rheumatology|January 23, 2024
Lupus low disease activity state and remission and risk of mortality in patients with systemic lupus erythematosus: a prospective, multinational, longitudinal cohort studyRangi Kandane-Rathnayake, Vera Golder, Worawit Louthrenoo, et al.
Rheumatology (Oxford, England)|May 19, 2023
SMART-SLE: serology monitoring and repeat testing in systemic lupus erythematosus-an analysis of anti-double-stranded DNA monitoringAi Li Yeo, Rangi Kandane-Rathnayake, Rachel Koelmeyer, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 19, 2022
Association of Modified Systemic Lupus Erythematosus Responder Index Attainment With Long-Term Clinical Outcomes: A Five-Year Prospective StudyKathryn Connelly, Rangi Kandane-Rathnayake, Alberta Hoi, et al.
Pageof 7